Ornillo, Zavier Kaleb D.
HRN: 26-13-89 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/25/2024
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
12/25/2024
01/01/2025
IV
45mg
Q24H
PCAP
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes